Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1

Oncogene

Volumn 12, Issue 6, 1996, Pages 1189-1198

  Dolnikov, Alla ^a,b   Ward, Robyn Lynne ^a   Hawkins, Nicholas John ^b   Symonds, Geoff ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Apoptosis; CSF 1; Transformation; v myc

Indexed keywords

COLONY STIMULATING FACTOR 1; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CULTURE; CELL DENSITY; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; HEAT SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MONOCYTE; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR CELL; TUMOR NECROSIS; TUMOR REGRESSION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DEXAMETHASONE; GENES, MYC; GROWTH SUBSTANCES; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MONOCYTES;

ANIMALIA; MURINAE;

EID: 0029967524     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Alitalo K, Ramsay G, Bishop JM, Pfeifer SO, Colby WW and Levinson AD. (1983). Nature, 306, 274-277.
2. Amati B, Littlewood TD, Evan GI and Land H. (1993a). EMBO J., 12, 5083-5087.
3. Amati B, Brooks MW, Levy N, Littlewood TD. (1993b). Cell, 72, 233-245.
4. Amin C, Wagner AJ and Hay N. (1993). Mol. Cell Biol., 13, 383-390.
5. Armelin HA, Armelin MCS, Kelly K, Stewart T, Leder P, Cochran BH, Stiles CD. (1984). Nature, 310, 655-660.
6. Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong SI, Takamoto S, Nomura K, Matsutani M, Takakura K and Kuchino Y. (1994). J. Neuro-oncol., 19, 259-268.
7. Askew DS, Ashmun RA, Simmons BC and Cleveland JL. (1991). Oncogene, 6, 1915-1922.
8. Baxter JD, Harris AW, Tompkins GM and Cohn M. (1971). Science, 171, 189-191.
9. Bissonnette RP, Echeverri F, Mahboubi A and Green DR. (1992). Nature, 359, 552-556.
10. Bonham L, Mackenzie K, Wood S, Rowe PB, Symonds G. (1992). Oncozene, 7, 2119-2229.
11. Bourgeois S and Newby RF. (1977). Cell, 11, 423-430.
12. Bradbury D, Shu YM, Hunter AE and Russell NH. (1992). Blood, 80 suppl. 1, 924a.
13. Chambers SK, Gilmore-Hebert M, Wang Y, Rodov S, Benz EJ and Kacinski BM. (1993). Exp. Hemat., 21, 1328-1334.
14. Chirgwin J, Przybyla H, McDonald R and Rutter W. (1979). Biochem., 18, 5294-5299.
15. Chisholm O, Stapleton P and Symonds G. (1992). Oncogene, 7, 1827-1836.
16. Clark SC and Kaner R. (1987). Science, 236, 1229-1237.
17. Cohen JJ. (1993). Immunology Today, 14, 126-130.
18. Darzynkievicz Z, Bruno S, De Bino G, Gorezyea W, Hotz MA, Lassota P and Fraganos F. (1992). Cytometry, 13, 795-808.
19. Davidoff AN and Mendelow BV. (1993). Exp. Hematol., 21, 922-927.
20. Deng G and Podack ER. (1993). Proc. Natl. Acad. Sci. USA, 90, 2189-2193.
21. Dolnikov A, Shounan Y, Hawkins NJ, Ward RL and Symonds G. (1995). Int. J. Oncol., 6, 633-639.
22. Dolnikov A, King A, Luxford C, Symonds G and Sur L. (1996). Cancer Gene Therapy, in press.
23. Eilers M, Schrim S and Bishop JM. (1991). EMBO J., 10, 133-141.
24. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
25. Facchini LM, Chen S and Penn LJZ. (1994). Cell, Growth and Differ., 5, 637-646.
26. Fukasawa Y, Ishikawa H, Takada A, Yokoyama S, Imaniwa M, Yoshiki J and Sato H. (1994). Am. J. Pathol., 144, 480-485.
27. Gavrieli Y, Sherman Y and Ben-Sasson SA. (1992). J. Cell. Biol., 119, 493-501.
28. Harrington EA, Fanidi A and Evan GI. (1994a). Curr. Opin. Genet. Dev., 4, 120-129.
29. Helmberg A, Auphan N, Caelles C and Karin M. (1995). EMBO J., 14, 452-460.
30. Howles KA, Ransom N, Papermaster DS, Lasudry GH, Albert DM, Windle JJ. (1994). Genes Dev., 8, 1300-1310.
31. Kato GJ, Barrett J, Villa Garcia M and Daug CV. (1990). Mol. Cell Biol., 10, 5914-5920.
32. Kowalik TF, DeGregori J, Schwarz JK and Nevins JR. (1995). J. Virol., 69, 2491-2500.
33. Ladner MB, Martin GA, Noble JA, Nikoloff DM, Tal R, Kawasaki ES and White TJ. (1987). EMBO J., 6, 2693-2698.
34. Lotem J and Sachs L. (1993). Cell Growth Diff., 4, 41-47.
35. Luscher B and Eisenman RN. (1990). Genes & Dev., 4, 2025-2035.
36. Marcu KB, Bossone SA and Patel AJ. (1992). Ann. Rev. Biochem., 61, 809-830.
37. Norman MR and Thompson EB. (1977). Cancer Res., 37, 3785-3791.
38. Raff MC. (1992). Nature, 356, 397-400.
39. Rustgi A, Dyson N and Bernards R. (1991). Nature, 352, 541-544.
40. Shan B and Lee W. (1994). Mol. Cell Biol., 17, 8166-8173.
41. Sibley CH and Thompkins GM. (1974). Cell, 2, 213-220.
42. Smith CA, Williams GT, Kingston R, Jenkinson EJ and Owen JJT. (1989). Nature, 337, 181-184.
43. Spencer CA and Groudine M. (1991). Adv. Cancer Res., 56, 1-48.
44. Stanley ER and Heard PM. (1977). J. Biol. Chem., 252, 4305-4307.
45. Stapleton P, Takayama Y, Hartshorn A, Kalaizis A, Rowe PB and Symonds G. (1991). Oncogene, 6, 807-817.
46. Wagner AJ, Small MB and Hay N. (1993). Mol. Cell Biol., 13, 2432-2440.
47. Wang Y, Ranquist T, Szekely L, Axelson H, Klein G and Wiman KG. (1993a). Cell Growth Diff., 4, 467-473.
48. Wang Y, Szekely L, Okan I, Klein G and Wiman KG. (1993b). Oncogene, 8, 3427-3431.
49. White E,. Cipriani R, Sabbatini P and Denton A. (1991). J. Virol., 65, 2968-2978.